Mersana Therapeutics, Inc. Depreciation
Mersana Therapeutics, Inc. reported Depreciation of $1.60 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2025-03-03
- Mersana Therapeutics, Inc. depreciation for fiscal 2024 was $1.60M, a 6.67% increase from fiscal 2023.
- Mersana Therapeutics, Inc. depreciation for fiscal 2023 was $1.50M, a 66.67% increase from fiscal 2022.
- Mersana Therapeutics, Inc. depreciation for fiscal 2022 was $900.00K, a 0.00% change from fiscal 2021.
- Mersana Therapeutics, Inc. depreciation for fiscal 2021 was $900.00K, a 10.00% decline from fiscal 2020.
| Period end | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|
| 2024-12-31 | $1.60M 10-K · filed 2025-03-03 | |
| 2023-12-31 | $1.50M 10-K · filed 2025-03-03 | |
| 2022-12-31 | $900.00K 10-K · filed 2025-03-03 | |
| 2021-12-31 | $900.00K 10-K · filed 2024-02-28 | $855.00K 10-K · filed 2022-02-28 |
| 2020-12-31 | $1.00M 10-K · filed 2023-02-28 | $1.01M 10-K · filed 2021-02-26 |
| 2019-12-31 | $1.25M 10-K · filed 2022-02-28 | |
| 2018-12-31 | $1.26M 10-K · filed 2021-02-26 | |
| 2017-12-31 | $928.00K 10-K · filed 2020-02-28 | |
| 2016-12-31 | $655.00K 10-K · filed 2019-03-08 | |
| 2015-12-31 | $297.00K 10-K · filed 2018-03-28 |